$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[국내논문] 바이러스성 위장염에 효과를 가지는 프로바이오틱스: 총설
Anti-Viral Activities of Probiotics against Viral Gastroenteritis: A Review 원문보기

Journal of dairy science and biotechnology, v.41 no.3, 2023년, pp.87 - 102  

천정환 (인제대학교 반려동물보건학과) ,  윤혜영 (건국대학교 수의과대학 및 원헬스연구소) ,  김현진 (건국대학교 수의과대학 및 원헬스연구소) ,  오형석 (건국대학교 수의과대학 및 원헬스연구소) ,  강석형 (서정대학교 반려동물과 및 동물보건과) ,  황원욱 (서정대학교 반려동물과 및 동물보건과) ,  정하정 (서정대학교 반려동물과 및 동물보건과) ,  김현주 (부천대학교 반려동물과) ,  서건호 (건국대학교 수의과대학 및 원헬스연구소) ,  송광영 (건국대학교 수의과대학 및 원헬스연구소)

Abstract AI-Helper 아이콘AI-Helper

Globally, acute gastroenteritis is responsible for two million pediatric deaths. In particular, viral gastroenteritis is the most common cause of acute diarrhea, and most children aged <5 years are infected at least once. The common symptoms include profuse watery diarrhea, vomiting, abdominal pain,...

Keyword

AI 본문요약
AI-Helper 아이콘 AI-Helper

문제 정의

  • 따라서 본 총설에서는 프로바이오틱스가 바이러스성 위장염에 대한 항바이러스제로서의 다양한 효과와 가능성 등에 대해서 자세하게 설명될 것이다. 또한 본 총설 논문에서 인용된 모든 자료들은 이미 발표된 여러가지 과학적인 자료 및 문헌 등을 조사하여 재정리하였다.
본문요약 정보가 도움이 되었나요?

참고문헌 (59)

  1. Al Kassaa I. Antiviral probiotics: a new concept in medical sciences. In: Al Kassaa?I, editor. New insights on antiviral probiotics. 1st ed. Cham, Switzerland: Springer?Nature; 2017. p. 14-46. 

  2. Gordon S. Elie Metchnikoff: father of natural immunity. Eur J Immunol. 2008;38:3257-3264. 

  3. Fouhy F, Ross RP, Fitzgerald GF, Stanton C, Cotter PD. Composition of the early?intestinal microbiota. Gut Microbes. 2012;3:203-220. 

  4. Collado MC, Isolauri E, Salminen S, Sanz Y. The impact of probiotic on gut health.?Curr Drug Metab. 2009;10:68-78. 

  5. Rodriguez JM, Murphy K, Stanton C, Ross RP, Kober OI, Juge N, et al. The?composition of the gut microbiota throughout life, with an emphasis on early life.?Microb Ecol Health Dis. 2015;26:26050. 

  6. Zoghi G, Moosavy SH, Yavarian S, HasaniAzad M, Khorrami F, Sharegi Brojeni M,?et al. Gastrointestinal implications in COVID-19. BMC Infect Dis. 2021;21:1135. 

  7. Tremaroli V, Backhed F. Functional interactions between the gut microbiota and?host metabolism. Nature. 2012;489:242-249. 

  8. Hooper LV, Stappenbeck TS, Hong CV, Gordon JI. Angiogenins: a new class of?microbicidal proteins involved in innate immunity. Nat Immunol. 2003;4:269-273. 

  9. Hakomori S. Antigen structure and genetic basis of histo-blood groups A, B and O:?their changes associated with human cancer. Biochim Biophys Acta. 1999;1473:247-266. 

  10. Newburg DS. Oligosaccharides in human milk and bacterial colonization. J Pediatr?Gastroenterol Nutr. 2000;30:S8-S17. 

  11. Aspinall GO, Monteiro MA. Lipopolysaccharides of Helicobacter pylori strains P466?and MO19: structures of the O antigen and core oligosaccharide regions. Biochemistry. 1996;35:2498-2504. 

  12. Andersson M, Carlin N, Leontein K, Lindquist U, Slettengren K. Structural studies?of the O-antigenic polysaccharide of Escherichia coli O86, which possesses blood-group B activity. Carbohydr Res. 1989;185:211-223. 

  13. Menon VK, George S, Sarkar R, Giri S, Samuel P, Vivek R, et al. Norovirus gastro- enteritis in a birth cohort in Southern India. PLOS ONE. 2016;11:e0157007. 

  14. Joshi SS, Howell AB, D'Souza DH. Reduction of enteric viruses by blueberry juice?and blueberry proanthocyanidins. Food Environ Virol. 2016;8:235-243. 

  15. Al Kassaa I, Hober D, Hamze M, Chihib NE, Drider D. Antiviral potential of lactic?acid bacteria and their bacteriocins. Probiotics Antimicrob Proteins. 2014;6:177-185. 

  16. Karst SM. The influence of commensal bacteria on infection with enteric viruses.?Nat Rev Microbiol. 2016;14:197-204. 

  17. Javier B, Rodriguez-Diaz J. Molecular virology of enteric viruses (with emphasis on?caliciviruses). In: Goyal SM, editor. Viruses in foods. New York, NY: Springer; 2006.?p. 43-100. 

  18. Uchiyama R, Chassaing B, Zhang B, Gewirtz AT. Antibiotic treatment suppresses?rotavirus infection and enhances specific humoral immunity. J Infect Dis. 2014;210:171-182. 

  19. Jones MK, Watanabe M, Zhu S, Graves CL, Keyes LR, Grau KR, et al. Enteric bacteria?promote human and mouse norovirus infection of B cells. Science. 2014;346:755-759. 

  20. Kernbauer E, Ding Y, Cadwell K. An enteric virus can replace the beneficial function?of commensal bacteria. Nature. 2014;516:94-98. 

  21. Baldridge MT, Nice TJ, McCune BT, Yokoyama CC, Kambal A, Wheadon M, et al.?Commensal microbes and interferon-λ determine persistence of enteric murine?norovirus infection. Science. 2015;347:266-269. 

  22. Kuss SK, Best GT, Etheredge CA, Pruijssers AJ, Frierson JM, Hooper LV, et al.?Intestinal microbiota promote enteric virus replication and systemic pathogenesis.?Science. 2011;334:249-252. 

  23. Robinson CM, Jesudhasan PR, Pfeiffer JK. Bacterial lipopolysaccharide binding?enhances virion stability and promotes environmental fitness of an enteric virus.?Cell Host Microbe. 2014;15:36-46. 

  24. Tan M, Jiang X. Norovirus and its histo-blood group antigen receptors: an answer?to a historical puzzle. Trends Microbiol. 2005;13:285-293. 

  25. Mukherji A, Kobiita A, Ye T, Chambon P. Homeostasis in intestinal epithelium is?orchestrated by the circadian clock and microbiota cues transduced by TLRs. Cell.?2013;153:812-827. 

  26. Wilks J, Lien E, Jacobson AN, Fischbach MA, Qureshi N, Chervonsky AV, et al.?Mammalian lipopolysaccharide receptors incorporated into the retroviral envelope?augment virus transmission. Cell Host Microbe. 2015;18:456-462. 

  27. Kahan SM, Liu G, Reinhard MK, Hsu CC, Livingston RS, Karst SM. Comparative?murine norovirus studies reveal a lack of correlation between intestinal virus titers?and enteric pathology. Virology. 2011;421:202-210. 

  28. Donnelly RP, Kotenko SV. Interferon-lambda: a new addition to an old family. J?Interferon Cytokine Res. 2010;30:555-564. 

  29. Nice TJ, Baldridge MT, McCune BT, Norman JM, Lazear HM, Artyomov M, et al.?Interferon-λ cures persistent murine norovirus infection in the absence of adaptive?immunity. Science. 2015;347:269-273. 

  30. Pott J, Mahlakoiv T, Mordstein M, Duerr CU, Michiels T, Stockinger S, et al. IFN-λ?determines the intestinal epithelial antiviral host defense. Proc Natl Acad Sci USA.?2011;108:7944-7949. 

  31. Howarth GS, Wang H. Role of endogenous microbiota, probiotics and their biological?products in human health. Nutrients. 2013;5:58-81. 

  32. Al Kassaa I, Hamze M, Hober D, Chihib NE, Drider D. Identification of vaginal?lactobacilli with potential probiotic properties isolated from women in North?Lebanon. Microb Ecol. 2014;67:722-734. 

  33. Liepke C, Adermann K, Raida M, Magert HJ, Forssmann WG, Zucht HD. Human milk?provides peptides highly stimulating the growth of bifidobacteria. Eur J Biochem.?2002;269:712-718. 

  34. Desselberger U. Rotaviruses. Virus Res. 2014;190:75-96. 

  35. Kam J, Demmert AC, Tanner JR, McDonald SM, Kelly DF. Structural dynamics of?viral nanomachines. Technology. 2014;2:44-48. 

  36. Guandalini S, Pensabene L, Zikri MA, Dias JA, Casali LG, Hoekstra H, et al.?Lactobacillus GG administered in oral rehydration solution to children with acute?diarrhea: a multicenter European trial. J Pediatr Gastroenterol Nutr. 2000;30:54-60. 

  37. Majamaa H, Isolauri E, Saxelin M, Vesikari T. Lactic acid bacteria in the treatment?of acute rotavirus gastroenteritis. J Pediatr Gastroenterol Nutr. 1995;20:333-338. 

  38. Shornikova AV, Casas IA, Isolauri E, Mykkanen H, Vesikari T. Lactobacillus reuteri?as a therapeutic agent in acute diarrhea in young children. J Pediatr Gastroenterol?Nutr. 1997;24:399-404. 

  39. Teran CG, Teran-Escalera CN, Villarroel P. Nitazoxanide vs. probiotics for the?treatment of acute rotavirus diarrhea in children: a randomized, single-blind, controlled trial in Bolivian children. Int J Infect Dis. 2009;13:518-523. 

  40. Grandy G, Medina M, Soria R, Teran CG, Araya M. Probiotics in the treatment of?acute rotavirus diarrhoea. A randomized, double-blind, controlled trial using two?different probiotic preparations in Bolivian children. BMC Infect Dis. 2010;10:253. 

  41. Seo BJ, Mun MR, Rejish Kumar VJ, Kim CJ, Lee I, Chang YH, et al. Bile tolerant?Lactobacillus reuteri isolated from pig feces inhibits enteric bacterial pathogens and?porcine rotavirus. Vet Res Commun. 2010;34:323-333. 

  42. Simakachorn N, Pichaipat V, Rithipornpaisarn P, Kongkaew C, Tongpradit P,?Varavithya W. Clinical evaluation of the addition of lyophilized, heat-killed?Lactobacillus acidophilus LB to oral rehydration therapy in the treatment of acute?diarrhea in children. J Pediatr Gastroenterol Nutr. 2000;30:68-72. 

  43. Maragkoudakis PA, Chingwaru W, Gradisnik L, Tsakalidou E, Cencic A. Lactic acid?bacteria efficiently protect human and animal intestinal epithelial and immune cells?from enteric virus infection. Int J Food Microbiol. 2010;141:S91-S97. 

  44. Liu F, Li G, Wen K, Bui T, Cao D, Zhang Y, et al. Porcine small intestinal epithelial?cell line (IPEC-J2) of rotavirus infection as a new model for the study of innate?immune responses to rotaviruses and probiotics. Viral Immunol. 2010;23:135-149. 

  45. Hagbom M, Sharma S, Lundgren O, Svensson L. Towards a human rotavirus disease?model. Curr Opin Virol. 2012;2:408-418. 

  46. Mao X, Gu C, Hu H, Tang J, Chen D, Yu B, et al. Dietary Lactobacillus rhamnosus?GG supplementation improves the mucosal barrier function in the intestine of?weaned piglets challenged by porcine rotavirus. PLOS ONE. 2016;11:e0146312. 

  47. Yang X, Twitchell E, Li G, Wen K, Weiss M, Kocher J, et al. High protective efficacy?of rice bran against human rotavirus diarrhea via enhancing probiotic growth, gut?barrier function and innate immunity. Sci Rep. 2015;5:15004. 

  48. Aoki-Yoshida A, Saito S, Fukiya S, Aoki R, Takayama Y, Suzuki C, et al. Lactobacillus rhamnosus GG increases Toll-like receptor 3 gene expression in murine?small intestine ex vivo and in vivo. Benef Microbes. 2016;7:421-429. 

  49. Chenoll E, Rivero M, Codoner FM, Martinez-Blanch JF, Ramon D, Genoves S, et al.?Complete genome sequence of Bifidobacterium longum subsp. infantis strain CECT?7210, a probiotic strain active against rotavirus infections. Genome Announc. 2015;3:e00105-15. 

  50. Debbink K, Lindesmith LC, Donaldson EF, Baric RS. Norovirus immunity and the?great escape. PLOS Pathog. 2012;8:e1002921. 

  51. Lindesmith L, Moe C, Marionneau S, Ruvoen N, Jiang X, Lindblad L, et al. Human susceptibility and resistance to Norwalk virus infection. Nat Med. 2003;9:548-553. 

  52. Aboubakr HA, El-Banna AA, Youssef MM, Al-Sohaimy SAA, Goyal SM. Antiviral?effects of Lactococcus lactis on feline calicivirus, a human norovirus surrogate.?Food Environ Virol. 2014;6:282-289. 

  53. Rubio-del-Campo A, Coll-Marques JM, Yebra MJ, Buesa J, Perez-Martinez G,?Monedero V, et al. Noroviral P-particles as an in vitro model to assess the?interactions of noroviruses with probiotics. PLOS ONE. 2014;9:e89586. 

  54. Hoang PM, Cho S, Kim KE, Byun SJ, Lee TK, Lee S. Development of Lactobacillus?paracasei harboring nucleic acid-hydrolyzing 3D8 scFv as a preventive probiotic?against murine norovirus infection. Appl Microbiol Biotechnol. 2015;99:2793-2803. 

  55. Bosch A, Pinto RM, Guix S. Human astroviruses. Clin Microbiol Rev. 2014;27:1048-1074. 

  56. Ganesh B, Richter J, Blaut M, Loh G. Enterococcus faecium NCIMB 10415 does not?protect interleukin-10 knock-out mice from chronic gut inflammation. Benef?Microbes. 2012;3:43-50. 

  57. Nguyen NTB, Pham HV, Hoang CQ, Nguyen TM, Nguyen LT, Phan HC, et al.?Epidemiological and clinical characteristics of children who died from hand, foot?and mouth disease in Vietnam, 2011. BMC Infect Dis. 2014;14:341. 

  58. Rosander A, Connolly E, Roos S. Removal of antibiotic resistance gene-carrying?plasmids from Lactobacillus reuteri ATCC 55730 and characterization of the resulting daughter strain, L. reuteri DSM 17938. Appl Environ Microbiol. 2008;74:6032-6040. 

  59. Ang LYE, Too HKI, Tan EL, Chow TKV, Shek PCL, Tham E, et al. Antiviral activity?of Lactobacillus reuteri Protectis against Coxsackievirus A and Enterovirus 71?infection in human skeletal muscle and colon cell lines. Virol J. 2016;13:111. 

저자의 다른 논문 :

관련 콘텐츠

오픈액세스(OA) 유형

GOLD

오픈액세스 학술지에 출판된 논문

이 논문과 함께 이용한 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로